 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

This price move could be a signal that CELC may fall back below the higher band and head toward the middle band. Traders may consider selling the stock, shorting the stock, or exploring put options...

Celcuity (CELC, $10.41) price may drop as it broke higher Bollinger Band on Sep 15, 2023

This is a Bullish indicator signaling CELC's price could rise from here. Traders may explore going long the stock or buying call options...

Celcuity (CELC, $9.48) Moving Average Convergence Divergence (MACD) Histogram turned positive on September 13, 2023

This is a signal that CELC's price trend could be reversing, and it may be an opportunity to buy the stock or explore call options...

Celcuity (CELC, $9.41) Stochastic Oscillator left the oversold zone on September 12, 2023

Leading key opinion leaders to review the treatment landscape in breast and prostate cancer and the importance of targeting the PI3K/mTOR pathway in hormonally driven tumor typesDiscussion of the...

Celcuity to Host Virtual Science Day for Investors

Celcuity (CELC, $9.01) Stochastic Oscillator left the oversold zone on September 06, 2023

This indicator may be signaling that CELC's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...

Celcuity (CELC, $9.39) entered Downtrend as Momentum indicator drops below 0 level on Sep 05, 2023

This is a Bearish indicator signaling CELC's price could decline from here. Traders may explore shorting the stock or put options...

Celcuity (CELC, $9.39) Moving Average Convergence Divergence (MACD) Histogram turned negative on September 5, 2023

Celcuity (CELC, $9.85) Stochastic Oscillator left the oversold zone on September 01, 2023

Celcuity (CELC, $9.85) Moving Average Convergence Divergence (MACD) Histogram turned positive on September 1, 2023

Celcuity (CELC, $9.53) entered Downtrend as Momentum indicator drops below 0 level on Aug 31, 2023

Celcuity, Inc. is cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. Its proprietary CELx diagnostic platform is the commercially ready technology that uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. The company was founded by Brian F. Sullivan and Lance G. Laing in January 2012 and is headquartered in Minneapolis, MN.

Watchers	634
52-Wk Low	$7.50
52-Wk High	$14.40

Market Cap	$220.46M
Volume (M)	47,704.00
52-Wk High	$14.40
52-Wk Low	$7.50

CELC Celcuity Inc

About

Feed

News

Sentiment

Earnings

Fundamentals